Multi-drug resistant HIV-1

被引：11
|
作者：
Omrani, AS [1 ]
Pillay, D
机构：
[1] Birmingham Heartlands Hosp, Dept Infect & Trop Med, Birmingham B9 5SS, W Midlands, England
[2] Univ Birmingham, Sch Med, PHLS Antiviral Susceptibil Reference Unit, Dept Infect,Div Immun & Infect, Birmingham, W Midlands, England
来源：
JOURNAL OF INFECTION | 2000年 / 41卷 / 01期
关键词：
D O I：
10.1053/jinf.2000.0702
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页码：5 / 11
页数：7
相关论文
共 50 条
  • [1] Tipranavir: a protease inhibitor for multi-drug resistant HIV-1
    Best, B
    Haubrich, R
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (01) : 59 - 70
  • [2] Transmission of Multi-Drug Resistant HIV-1 Despite Antiretroviral Prophylaxis
    Soriano, Vicente
    [J]. AIDS REVIEWS, 2017, 19 (01) : 55 - 55
  • [3] Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside β-triphosphates
    Dash, Chandravanu
    Ahmadibeni, Yousef
    Hanley, Michael J.
    Pandhare, Jui
    Gotte, Mathias
    Le Grice, Stuart F. J.
    Parang, Keykavous
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3519 - 3522
  • [4] Crystal structures of four multi-drug resistant HIV-1 proteases and implications for drug design
    Kovari, LC
    Vickrey, JF
    Martin, P
    Proteasa, G
    Yedidi, R
    Kovari, I
    Martinez, J
    MacArthur, R
    Spaller, M
    Wawrzak, Z
    Winters, MA
    Merigan, TC
    [J]. ANTIVIRAL THERAPY, 2005, 10 (04) : S113 - S113
  • [5] Crystal structures of four multi-drug resistant HIV-1 proteases and implications for drug design
    Kovari, LC
    Vickrey, JF
    Martin, P
    Proteasa, G
    Yedidi, R
    Kovari, I
    Martinez, J
    MacArthur, R
    Spaller, M
    Wawrzak, Z
    Winters, MA
    Merigan, TC
    [J]. ANTIVIRAL THERAPY, 2005, 10 : S113 - S113
  • [6] Multi-drug resistant HIV-1 are transmitted more frequently than current estimates
    Johnson, JA
    Li, JF
    Brant, A
    Bennett, D
    Cong, M
    Spira, T
    Sandstrom, P
    Heneine, W
    [J]. ANTIVIRAL THERAPY, 2005, 10 (04) : S124 - S124
  • [7] Sexual transmission of multi-drug resistant HIV-1: evidence for complex viral evolution
    Taylor, S
    Cane, F
    Clarke, J
    Hextall, R
    Workman, J
    Radcliffe, D
    Ball, J
    Pillay, D
    [J]. AIDS, 2000, 14 : S117 - S118
  • [8] Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease
    Dewdney, Tamaria G.
    Wang, Yong
    Liu, Zhigang
    Sharma, Shiv K.
    Reiter, Samuel J.
    Brunzelle, Joseph S.
    Kovari, Iulia A.
    Woster, Patrick M.
    Kovari, Ladislau C.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (23) : 7430 - 7434
  • [9] Multi-drug resistant HIV-1 are transmitted more frequently than current estimates
    Johnson, JA
    Li, JF
    Brant, A
    Bennett, D
    Cong, M
    Spira, T
    Sandstrom, P
    Heneine, W
    [J]. ANTIVIRAL THERAPY, 2005, 10 : S124 - S124
  • [10] Optimal control for HIV-1 multi-drug therapy
    Magombedze, Gesham
    Garira, Winston
    Mwenje, Eddie
    Bhunu, Claver Pedzisai
    [J]. INTERNATIONAL JOURNAL OF COMPUTER MATHEMATICS, 2011, 88 (02) : 314 - 340
12345